ArticleCancer letters2023

Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response.

Emily K Kleczko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.